89bio Inc (NASDAQ: ETNB) started the day on Wednesday, with a price decrease of -1.36% at $7.26, before settling in for the price of $7.36 at the close. Taking a more long-term approach, ETNB posted a 52-week range of $6.57-$16.63.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. Meanwhile, its Annual Earning per share during the time was -11.24%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -11.14%. This publicly-traded company’s shares outstanding now amounts to $105.91 million, simultaneously with a float of $99.24 million. The organization now has a market capitalization sitting at $768.91 million. At the time of writing, stock’s 50-day Moving Average stood at $8.39, while the 200-day Moving Average is $9.50.
89bio Inc (ETNB) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. 89bio Inc’s current insider ownership accounts for 6.30%, in contrast to 96.49% institutional ownership. According to the most recent insider trade that took place on Apr 01 ’24, this organization’s Chief Executive Officer sold 52,718 shares at the rate of 10.91, making the entire transaction reach 575,153 in total value, affecting insider ownership by 459,171. Preceding that transaction, on Mar 04 ’24, Company’s Director bought 1,350,000 for 15.35, making the whole transaction’s value amount to 20,722,500. This particular insider is now the holder of 12,431,584 in total.
89bio Inc (ETNB) Earnings and Revenue Records
89bio Inc’s EPS decrease for this current 12-month fiscal period is -11.14% and is forecasted to reach -2.53 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 11.00% through the next 5 years, which can be compared against the -11.24% growth it accomplished over the previous five years trading on the market.
89bio Inc (NASDAQ: ETNB) Trading Performance Indicators
Let’s observe the current performance indicators for 89bio Inc (ETNB). It’s Quick Ratio in the last reported quarter now stands at 13.92. The Stock has managed to achieve an average true range (ATR) of 0.44.
In the same vein, ETNB’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.97, a figure that is expected to reach -0.62 in the next quarter, and analysts are predicting that it will be -2.53 at the market close of one year from today.
Technical Analysis of 89bio Inc (ETNB)
If we take a close look at the recent performances of 89bio Inc (NASDAQ: ETNB), its last 5-days Average volume was 0.82 million that shows plunge from its year to date volume of 0.99 million. During the previous 9 days, stock’s Stochastic %D was recorded 15.43% While, its Average True Range was 0.40.
Raw Stochastic average of 89bio Inc (ETNB) in the period of the previous 100 days is set at 8.70%, which indicates a major fall in contrast to 11.04% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 39.14% that was lower than 59.46% volatility it exhibited in the past 100-days period.
